Investing.com - GlaxoSmithKline ADR reported on Wednesday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
GlaxoSmithKline ADR announced earnings per share of £0.19 on revenue of £7.6B. Analysts polled by Investing.com anticipated EPS of £0.49 on revenue of £9.64B.
GlaxoSmithKline ADR shares are down 12.11% from the beginning of the year and are trading at £40.91 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% from the start of the year.
GlaxoSmithKline ADR shares lost 0.94% in pre-market trade the report.
GlaxoSmithKline ADR follows other major Healthcare sector earnings this month
GlaxoSmithKline ADR's report follows an earnings beat by J&J on Thursday, July 16, 2020, who reported EPS of £1.67 on revenue of £18.34B, compared to forecasts EPS of £1.49 on revenue of £17.61B.
Roche Holding ADR had beat expectations on Thursday, July 23, 2020 with second quarter EPS of £1.45 on revenue of £15.27B, compared to forecast for EPS of £1.42 on revenue of £15.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar